Z-1696-2023 Class III Ongoing

Recalled by Abbott Ireland Limited — Sligo

FDA device recall Z-1696-2023 was initiated by Abbott Ireland Limited on April 24, 2023 and is designated Class III. Reason for recall: Due to a manufacturing fill volume error, Alinity i Anti-TPO Reagent contains a marginally lower fill volume than detailed in the Kit Contents section of the Instructions for Use (IFU). The recall status is ongoing. Affected quantity: 110 kits.

Recall Details

Product Type
Devices
Report Date
June 14, 2023
Initiation Date
April 24, 2023
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
110 kits

Product Description

Alinity i Anti-TPO Reagent Kit, List Number 09P3521

Reason for Recall

Due to a manufacturing fill volume error, Alinity i Anti-TPO Reagent contains a marginally lower fill volume than detailed in the Kit Contents section of the Instructions for Use (IFU).

Distribution Pattern

US Nationwide distribution in the states of CA, CO, FL, GA, IL, KY, LA, MD, MI, MN, NJ, NY, OH, RI, SC, SD, TN, TX, WA. No international distribution of affected lot.

Code Information

UDI Number: (01)00380740153892(17)240720(10)46009FN00; List Number: 09P3521; Lot Number: 46009FN00; Expiration Date: 07/20/2024